Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma

被引：54

作者：

Dummer, R ^{[1
]}

Panizzon, R ^{[1
]}

Bloch, PH ^{[1
]}

Burg, G ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland

来源：

DERMATOLOGY | 2005年 / 210卷 / 01期

关键词：

cutaneous melanoma; Swiss melanoma guidelines;

D O I：

10.1159/000081482

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Melanoma is the most common lethal cutaneous neoplasm. In order to harmonize treatment and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland have been inaugurated in 2001. These have been approved by all Swiss medical societies involved in the care of melanoma patients. New data necessitated changes concerning the safety margins (reduction to maximally 2 cm) and modifications of the recommendations of follow-up. Copyright (C) 2005 S. Karger AG, Basel.

引用

页码：39 / 44

页数：6

共 29 条

[1] Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma
Agarwala, SS
Glaspy, J
O'Day, SJ
Mitchell, M
Gutheil, J
Whitman, E
Gonzalez, R
Hersh, E
Feun, L
Belt, R
Meyskens, F
Hellstrand, K
Wood, D
Kirkwood, JM
Gehlsen, KR
Naredi, P
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 125 - 133
[2] *AUSTR CANC NETW, 1997, GUID MAN CUT MEL
[3] Balch CM, 2000, CANCER-AM CANCER SOC, V88, P1484, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO
[4] 2-D
[5] Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
Balch, CM
Buzaid, AC
Soong, SJ
Atkins, MB
Cascinelli, N
Coit, DG
Fleming, ID
Gershenwald, JE
Houghton, A
Kirkwood, JM
McMasters, KM
Mihm, MF
Morton, DL
Reintgen, DS
Ross, MI
Sober, A
Thompson, JA
Thompson, JF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3635 - 3648
[6] Epiluminescence microscopy of small pigmented skin lesions: Short-term formal training improves the diagnostic performance of dermatologists
Binder, M
PuespoeckSchwarz, M
Steiner, A
Kittler, H
Muellner, M
Wolff, K
Pehamberger, H
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (02) : 197 - 202
[7] Serum S100 - A marker for disease monitoring in metastatic melanoma
Dummer, R
JollerJemelka, HI
Boni, R
Burg, G
[J]. DERMATOLOGY, 1997, 194 (03) : 208 - 212
[8] Swiss guidelines for the treatment and follow-up of cutaneous melanoma
Dummer, R
Bösch, U
Panizzon, R
Bloch, PH
Burg, G
[J]. DERMATOLOGY, 2001, 203 (01) : 75 - 80
[9] Eggermont Alexander M M, 2002, Expert Rev Anticancer Ther, V2, P563, DOI 10.1586/14737140.2.5.563
[10] A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays
Farshad, A
Burg, G
Panizzon, R
Dummer, R
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (06) : 1042 - 1046

← 1 2 3 →